{
  "functional_evidence_assessment": [
    {
      "variant_id": "G2019S R117H",
      "variant_string_id": "G2019S R117H",
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "L",
        "alt": "R",
        "position": "117"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that patients with LRRK2 mutations show late onset and are indistinguishable from idiopathic disease patients.",
          "judgment": "Yes",
          "reasoning": "The mechanism is explicitly described in the text as related to Parkinson disease pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The studies are in vitro and focus on enzyme activity, phosphotransferase, and kinase activity.",
          "judgment": "Yes",
          "reasoning": "The assays are standard in the field and directly validate the pathogenicity of the mutations."
        },
        {
          "step_name": "Step 3: Validity of the assay (basic controls/replicates)",
          "extracted_paper_info": "Multiple replicates were performed in triplicate, with wild-type and loss-of-function controls used.",
          "judgment": "Yes",
          "reasoning": "Basic controls are provided, supporting the validity of the assay."
        },
        {
          "step_name": "Step 4: Apply evidence to individual interpretation",
          "extracted_paper_info": "No direct OddsPath calculation, but the association with pathogenicity is inferred.",
          "judgment": "Yes",
          "reasoning": "The absence of OddsPath data allows inference based on prior associations with PD."
        }
      ],
      "final_strength": "PS3_very_strong"
    }
  ]
}